On October 24, 2022 PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, reported that the Company is invited at upcoming Jefferies 2022 London Healthcare Conference. Jefferies is scheduled to be held in London from November 15-17, 2022 (Press release, PharmAbcine, OCT 24, 2022, View Source [SID1234622322]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the events are as follows:

Event: Jefferies 2022 London Healthcare Conference
Date: November 15-17, 2022
Event Calendar: View Source

Jefferies London Healthcare Conference is one of the largest healthcare-dedicated conference in Europe. In the past conference, over 550 companies and 3,000 attendees from Americas, Europe, Middle East, Africa, and Asia have joined the event.

At Jefferies, Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, will hold meetings with registered members of the investor community to look for investment opportunities and discuss the current trends in drug development and healthcare sector. The registered members will include leading global executives, institutional investors, and private equity investors.

To schedule a one-on-one meeting with PharmAbcine, contact the assigned Jefferies representative.